1Berrasconi E,Battegay M. Lamivudine for chronic hepatitis B[J]. N Engl J,1998,339(24):1786-787.
2Lai CL,Chien RN,Leung NW,et al. A one-year trial of lamivudine for chronic hepatitis B. Asia hepatitis lamivudine study[M]. N Engl J Med,1998:339.
3Chayama K,Suzuki Y,Kobayashi M,et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy[J]. Hepatology,1998,27(6):1711-1716.
4Tipples GA,Ma MM,Fischer KP,et al. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo[J]. Hepatology,1996,24:714-717.
5Satsuki Kobayashi,Tatsuya Ide,Michio Sata. Detection of YMDD motif Mutation in some lamivudine-untreated asymptomatic hepatitis B virus carriers[J]. J Hepatol,2001,34:584-586.
